I was interested in any clinical trial updates for 1. AMG509, 2. Janux007, and 3. any info regarding the new clinical trial being/have launched by Jaansen..
update on some clinical trials - Advanced Prostate...
update on some clinical trials


I know one thing it is hard to get enrollment in AMG509 and Janux007
i didnt know that; thanks
Information regarding clinical trials AMG509, Janux007, and any information regarding new clinical trials launched by Jaansen..
ChatGPT said:
Certainly, here's the information regarding the clinical trials for AMG 509, JANX007, and recent clinical trials initiated by Janssen:
AMG 509 Clinical Trials:
AMG 509 is an investigational therapy being evaluated for the treatment of metastatic castration-resistant prostate cancer (mCRPC). A Phase 1 study is assessing its safety, tolerability, pharmacokinetics, and efficacy in men with mCRPC. The trial includes participants who have previously undergone novel antiandrogen therapies and may have received one or two taxane regimens. The study is being conducted at multiple centers, including Memorial Sloan Kettering Cancer Center.
MSKCC.ORG
JANX007 Clinical Trials:
JANX007 is a T cell engager developed by Janux Therapeutics, targeting prostate-specific membrane antigen (PSMA) for the treatment of mCRPC. A first-in-human, Phase 1, open-label, multicenter study is underway to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of JANX007 in adults with mCRPC. The trial is enrolling participants across multiple sites in the United States and Australia.
JANUXRX.COM
Recent Clinical Trials by Janssen:
Janssen Pharmaceuticals is actively involved in numerous clinical trials across various therapeutic areas. They sponsor and support clinical trials in more than 40 countries, aiming to develop effective new medicines and treatments. For the most up-to-date information on Janssen's ongoing and upcoming clinical trials, you can visit their Global Trial Finder.
GLOBALTRIALFINDER.JANSSEN.COM
If you have specific questions about any of these trials or need assistance with enrollment, feel free to ask.
Good Luck, Good Health and Good Humor.
j-o-h-n